Massachusetts General Hospital is conducting a new study to evaluate the effects of GanedenBC30Æ on individuals with Irritable Bowel Syndrome (IBS) and Major Depressive Disorder (MDD).
Are you a leader in research & development? Stay ahead of the curve with Prepared Foods, the premier source of information and insights for today's trend leaders and taste-makers in food and beverage manufacturing.
